Jesse Shefferman - 19 Jan 2024 Form 4 Insider Report for Protara Therapeutics, Inc. (TARA)

Signature
/s/ Jesse Shefferman
Issuer symbol
TARA
Transactions as of
19 Jan 2024
Transactions value $
-$14,904
Form type
4
Filing time
23 Jan 2024, 16:05:31 UTC
Previous filing
12 Jan 2024
Next filing
30 Aug 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TARA Common Stock Award $0 +59,000 +6.6% $0 951,867 19 Jan 2024 Direct F1
transaction TARA Common Stock Tax liability -$14,903 -7,803 -0.82% $1.91 944,064 19 Jan 2024 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TARA Stock Option (Right to Buy) Award $0 +357,000 $0 357,000 19 Jan 2024 Common Stock 357,000 $1.91 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares being reported are being issued pursuant to restricted stock unit awards (RSUs), each of which represents a contingent right to receive one share of Issuer's common stock. The RSUs vest in equal one-third installments on the first, second and third anniversaries of January 19, 2024.
F2 25% of the shares vest on the one year anniversary of January 19, 2024 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date.
F3 Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 19, 2023.